Our auditor Anthony Bourasseau has finalised 2 MQAS audits on 2 CAPA follow-up visits in Turkey. This week he is in Iraq starting a Local Market Assessment with 8 GSDP technical visits. He will be in Baghdad, Erbil and Duhok. The country office of INTERSOS (www.intersos.org) is doing a great job coordinating this LMA locally. ...
We are starting the new year off with MQAS audits. Our quality compliance coordinator and leading MQAS auditor, Mr Anthony Bourasseau, is now in Turkey to conduct 2 MQAS audits and for CAPA follow-up visits with 2 pharmaceutical suppliers that were audited some time ago. Following these visits, he will travel to Iraq for a ...
Dear Friends, Regulatory agencies are responsible for collecting and evaluating spontaneous reports of suspected problems related to medications, including those from substandard medicines (SM). As the first mailing of 2022, I am sharing the attached article (Fedalto et al. Reports of substandard medicines: a lexicographic analysis of the Brazilian Health Surveillance Report System. Rev Ciênc ...
Dear Subscribers, QUAMED (www.quamed.org) is a not-for-profit organisation specialising in various aspects of pharmaceutical quality assurance. We conduct pharmaceutical assessments and audits, we develop and facilitate training courses around pharmaceutical quality, auditing and inspection and we organise and provide technical assistance in the field of pharmaceutical quality assurance. We have started two projects that have ...
Pharmaceutical public health is an emerging field in global health -and global health needs a generation of policy-makers who understand the relevance of coherent and integrated pharmaceutical systems. Pharmaceutical systems are essential to provide equitable, affordable access to appropriately used essential medical products. Unfortunately, they face major challenges in many countries, like the lack of ...
This WHO Medical Product Alert refers to one batch of falsified Combiart (combination of artemether and lumefantrine) that was identified in Chad, Côte d’Ivoire, and Mali and reported to WHO in November 2021. The falsified product was reported at the patient level outside authorized and regulated supply chains of the above-mentioned countries.Genuine Combiart is indicated ...
Dear members and partners, We would like to thank you for the wonderful opportunities that you have offered us in 2021. Despite the ongoing pandemic, you have been instrumental in helping us recover from a year with almost no activities (2020) and have made 2021, the most successful year yet for QUAMED We would like ...
QUAMED has finalised an MQAS audit report of CAMEBU, the central medical store in Burundi. The audit was made possible by the financial contributions of Artsen Zonder Vakantie (Medicines Sans Vacances), CAMEBU itself and Action Damien. The audit was done by one of our most experienced auditors Mr Jean-Christophe Pelissier. He also conducted three GSDP ...
Our auditor, Mr. George Mugi, has finalised 4 GSDP audits in Mozambique and has returned home safely. Our pipeline is filling up: we are preparing local market assessments (LMA) in Chad, Sudan, Yemen, Myanmar and Nigeria. In January 2022, we have planned up to 6 MQAS audits in Turkey and Mozambique and 8 GSDP technical ...
We are happy to announce that the board of QUAMED has accepted the membership application of Dr Prosper Hiag. Dr Hiag is a leader in the pharmaceutical sector, a social entrepreneur and an advocate for access to quality medicines in Africa and the use of WHO Good Manufacturing Practices for drugs conception and promoter of local ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.